Manila: Growing up in Cebu, Lucio Chua Tan Sr. sometimes attended school barefoot. In his teens, he took on manual jobs, as ...

Mega Motor Company (MMC), in partnership with BYD, the world’s no.1 New Energy Vehicle (NEV) manufacturer, announced the ...

Mega Motor Company (MMC), in partnership with BYD, the world’s no.1 New Energy Vehicle (NEV) manufacturer, announced the ...

Cloover targets $500m sales volume in 2026 underscoring the explosive demand for distributed energy solutions. Rising energy demand by AI, grid instability, and the expansion of electric mobility are ...

MMC Ports Holdings Bhd, Malaysia’s largest port operator and manager of key transhipment hubs, will focus on executing ...

Russian stocks ended Mondays trading session higher, with the MOEX Russia Index posting moderate gains as strong performances ...

The Food and Drug Administration on Monday approved a pill version of Wegovy, Novo Nordisk’s blockbuster weight loss drug. The Wegovy pill, as it’s called, is first oral version of a GLP-1 drug that ...

Marsh & McLennan is the global leader in insurance brokerage, commanding a 22% market share and operating in 130+ countries. MMC’s diversified business model, scale, and digital/AI innovation drive ...

The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug. By Gina Kolata Gina Kolata has ...

Your defended weight range can gradually shift upward through hormonal, metabolic, environmental, and microbiome-driven changes that push the body toward higher weight. Questions about why weight gain ...

Research shows the battle to keep weight off isn’t about willpower—it’s biology. Here’s how scientists say we can work with our bodies, not against them. Our bodies evolved to survive famine, not ...

Some people may notice weight gain while using Ozempic or after stopping the drug. Reasons for weight gain while using Ozempic may include changes in appetite and reduced physical activity due to side ...